TWST 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
價值面評分中等，已經有部位可以持續持有，若想建立新部位可以等待價值評分轉變為4分以上、股利提升為2分以上
TWST 近期報酬表現
1.48%
Twist bioscience corp
1.05%
同產業平均
0.48%
S&P500
與 TWST 同產業的標的表現
| 股票代碼 | 公司名稱 | 價值 | 趨勢 | 波段 | 籌碼 | 股利 | 加入追蹤 |
|---|---|---|---|---|---|---|---|
ADPT | Adaptive biotechnologies corp | 4 分 | 4 分 | 3 分 | 3 分 | 1 分 | |
VCYT | Veracyte inc | 3 分 | 3 分 | 2 分 | 2 分 | 1 分 | |
TXG | 10x genomics inc | 2 分 | 1 分 | 1 分 | 3 分 | 1 分 | |
DNLI | Denali therapeutics inc | 4 分 | 3 分 | 2 分 | 3 分 | 1 分 | |
DNA | Ginkgo bioworks holdings inc | 2 分 | 1 分 | 2 分 | 3 分 | 1 分 |
- ADPT Adaptive biotechnologies corp價值 4 分趨勢 4 分波段 3 分籌碼 3 分股利 1 分查看更多
TWST 公司資訊
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that develops manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. It has miniaturized traditional chemical DNA synthesis reactions to write over one million short pieces of DNA on each silicon chip. It offers two product lines: synthetic biology tools and NGS tools, that address different needs of its customers across a variety of applications. It offers ribonucleic acid and protein products. Its synthetic biology products include synthetic genes and gene fragments, and oligonucleotide or oligo pools.